recent articles
England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably. England’s first centre of its kind is set to make significant improvements in cancer...
Massive Bio: New partnership brings accurate trial recommendations to Azra AI’s national client base of medical systems and hospitals, including leading healthcare providers NEW YORK & FRANKLIN, Tenn.--(BUSINESS WIRE)--Massive Bio, a...
Andwin Scientific and Mikroscan Bring Leading Telemicroscopy Techno...
Mikroscan: Clinical research supplier to offer telemicroscopy systems that improve pathology services in clinical trials September 1, 2021 (Simi Valley, CA) - Andwin Scientific, the leading provider of outsourced clinical research supply...
PathAI, Bristol Meyers Squibb: Evolving strategic relationship will drive the use of artificial intelligence (AI)-powered pathology in translational research and clinical trials BOSTON — August 25, 2022 — PathAI, a global leader in...
In a tongue twister of a collaboration, partners Paige and Perspectum plan to pool pathology tools to progress prospective studies. Both companies are developing artificial intelligence-powered software that analyzes standard tissue...
Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its state-of-the-art spatial biology platform TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, an AI-powered...